Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 2—February 2025
Dispatch

Outbreak of Serotype 1 Invasive Pneumococcal Disease, Kibera Urban Informal Settlement, Nairobi, Kenya, 2023

Terry KomoComments to Author , Patrick K. Munywoki, Maria da Gloria Carvalho, Joshua Auko, Alice Ouma, Allan Audi, George O. Agogo, Daniel Omondi, Arthur Odoyo, Herine Odiembo, Newton Wamola, Mike Osita, Clayton Onyango, Naomi Lucchi, Peninah Munyua, Amy Herman-Roloff, Shanda Larson, Sopio Chochua, Fabiana C. Pimenta, Godfrey Bigogo, and Jennifer R. Verani
Author affiliation: Kenya Medical Research Institute, Kisumu, Kenya (T. Komo, J. Auko, A. Ouma, A. Audi, D. Omondi, A. Odoyo, H. Odiembo, N. Wamola, M. Osita, G.O. Bigogo); US Centers for Disease Control and Prevention, Nairobi (P.K. Munywoki, G.O. Agogo, C. Onyango, N. Lucchi, P. Munyua, A. Herman-Roloff); US Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. da Gloria Carvalho, S. Larson, S. Chochua, F.C. Pimenta, J.R. Verani)

Main Article

Figure 2

Serotype distribution among invasive pneumococcal disease carriage isolates, Kibera Urban Informal Settlement, Nairobi, Kenya, January 1, 2018–August 20, 2024. Other PCV10 serotypes are those common to Synflorix 10-valent PCV (GlaxoSmithKline, https://www.gsk.com) and Pneumosil 10-valent PCV (Serum Institute of India, https://www.seruminstitute.com) (5, 6B, 7F, 9V, 15, 19F, and 23F), Synflorix unique (4 and 18C), and Pneumosil unique (6A and 19A). PCV10, 10-valent pneumococcal conjugate vaccine; ST1, serotype 1.

Figure 2. Serotype distribution among invasive pneumococcal disease carriage isolates, Kibera Urban Informal Settlement, Nairobi, Kenya, January 1, 2018–August 20, 2024. Other PCV10 serotypes are those common to Synflorix 10-valent PCV (GlaxoSmithKline, https://www.gsk.com) and Pneumosil 10-valent PCV (Serum Institute of India, https://www.seruminstitute.com) (5, 6B, 7F, 9V, 15, 19F, and 23F), Synflorix unique (4 and 18C), and Pneumosil unique (6A and 19A). PCV10, 10-valent pneumococcal conjugate vaccine; ST1, serotype 1.

Main Article

Page created: January 02, 2025
Page updated: January 16, 2025
Page reviewed: January 16, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external